SVA - Sinovac Biotech Ltd.
This page shows which of the focused investors we track hold SVA and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2013 it was held by 1 manager with an aggregate reported value of $7.21M, which is 0.00% of the combined portfolio.
As of Q4 2013, 1 tracked institutional manager held SVA (Sinovac Biotech Ltd.) with an aggregate reported value of $7.21M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades SVA — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2013
- Ticker
- SVA
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Christopher Davis - Davis Advisors | 0.02% | Reduce -20.0% | 1,178,606 | $7.21M |
Loading holder history for SVA…